Q: I know it is a risky penny stock, but can you provide a brief overview of what you think of this company? Valuation, growth prospects, balance sheet health etc.
Thanks,
Thanks,
5i Research Answer:
Market cap is $17M, with a 35% decline this year and a 36% gain over 52 weeks. Insiders own 12.5%, Threed Capital owns 12%. Revenue is minimal, showing $0.4M in the last 12 months. Net cash is $1.7M, plus $2M just raised. It has lost money since at least 2015 and cash flow is negative (-$2.7M last 12 months). There is not a lot yet to analyse here. It is focused on AI and health, and has several investments at the early stages. It recently took a loss on a subsidiary and has decided to exit it. No analysts cover it and we have no growth projections. We would consider it, at best, a lottery ticket at this time.